PMCTPharmaCountry
    Home

2212021-61-7

EnBridge PharmTech (Wuxi) Co., Ltd.
EnBridge PharmTech (Wuxi) Co., Ltd.
API Manufacturer · Active Pharmaceutical Ingredients (APIs)Flag of CNChina

Basic Information

850
56
18
4.6(80)

Category

Laboratory Chemicals, Solvents & Reference Standards

Subcategory & Sub-subcategory

Reagents & Buffers / Other Specialized Reagents

Trade Type

Sell

Product Name

2212021-61-7

Details

2212021-61-7

Substance

5H-Pyrazolo(4,3-c)pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-

Manufacturer(s)

Specifications

  • CAS Number: 2212021-61-7
  • Chemical Formula: C23H28FN5O3
  • Purity: Pharmaceutical-grade material
  • IUPAC Name: tert-butyl (4S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-1H-imidazol-3-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate
  • EC Number: 895-461-5
  • Molecular Weight: 441.5
  • Certification Standard: In-house quality standard
  • Application: API synthesis intermediate

Other Information

Additional Description:

This compound, identified by CAS 2212021-61-7, is a pharmaceutical-grade API intermediate manufactured directly by EnBridge PharmTech (Wuxi) Co., Ltd, marketed generically as a cost-effective, stable-supply product without further identifying detail. It is distributed to North America, Western Europe and Asia.
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More